Modulation of [3H]dopamine release by glutathione in mouse striatal slices

Neurochemical Research

Volumn 32, Issue 8, 2007, Pages 1357-1364

  Janáky, Réka ^a   Dohovics, Róbert ^a   Saransaari, Pirjo ^a   Oja, Simo S ^b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Dopamine release; Glutathione; Glutathione derivatives; Striatal slices

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CYSTEINE; CYSTINE; DITHIOTHREITOL; DOPAMINE; GLUTAMATE RECEPTOR AGONIST; GLUTATHIONE; GLUTATHIONE DERIVATIVE; GLUTATHIONE DISULFIDE; GLUTATHIONE SULFONATE; GLYCINE; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; POTASSIUM; THIOL DERIVATIVE; TRITIUM; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR STIMULATING AGENT; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; EVOKED RESPONSE; FEMALE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; ANIMAL; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; SECRETION;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; KAINIC ACID; MICE; OXIDATION-REDUCTION; POTASSIUM; TRITIUM;

EID: 34250796230     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9315-z     Document Type: Article

References (46)

1. Lenhoff HM (1998) The discovery of the GSH receptor in hydra and its evolutionary significance. In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, Washington, DC, pp 25-43
2. Shaw CA (1998) Multiple roles of glutathione in the nervous system. In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, Washington, DC, pp 3-23
3. Janáky R, Shaw CA, Varga V, Hermann A, Dohovics R, Saransaari P, Oja SS (2000) Specific glutathione binding sites in pig cerebral cortical synaptic membranes. Neuroscience 95:617-624
4. Shaw CA, Pasqualotto BA, Curry K (1996) Glutathione-induced sodium currents in neocortex. Neuroreport 7:1149-1152
5. Zängerle L, Cuénod M, Winterhalter KH, Do KQ (1992) Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J Neurochem 59:181-189
6. 3H]glutamate in rat brain. Life Sci 39:2411-2418
7. Oja SS, Varga V, Janáky R, Kontro P, Aarnio T, Marnela K-M (1988) Glutathione and glutamatergic neurotransmission in the brain. In: Cavalheiro EA, Lehmann J, Turski L (eds) Frontiers in excitatory amino acid research. Alan R Liss, New York, pp 75-78
8. Varga V, Janáky R, Marnela K-M, Gulyás J, Kontro P, Oja SS (1989) Displacement of excitatory amino acid receptor ligands by acidic oligopeptides. Neurochem Res 14:1223-1227
9. 3H]GABA evoked by glutamate agonists from hippocampal slices: effects of dithiothreitol and glutathione. Neurochem Int 24:575-582
10. Oja SS, Janáky R, Saransaari P, Jenei Zs, Varga V (1995) Interaction of glutathione derivatives with brain 2-amino-3-hydroxy-5-methyl-4- isoxazolepropionate (AMPA) receptors. Proc West Pharmacol Soc 38:9-11
11. Janáky R, Varga V, Jenei Zs, Saransaari P, Oja SS (1998) Glutathione and glutathione derivatives: possible modulators of ionotropic glutamate receptors. In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, Washington, DC, pp 163-196
12. 3H]α-amino-3-hydroxy-5-methylisoxazole-4- propionic acid binding to rat telencephalic membranes. Mol Pharmacol 34:117-123
13. Aizenman E., Lipton SA, Loring RH (1989) Selective modulation of NMDA responses by reduction and oxidation. Neuron 2:1257-1263
14. Janáky R, Ogita K, Pasqualotto BA, Bains JS, Oja SS, Yoneda Y, Shaw CA (1999) Glutathione and signal transduction in the mammalian CNS. J Neurochem 73:889-902
15. Perry TL, Godin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci Lett 33:305-310
16. Bannon MJ, Goedert M, Williams B (1984) The possible relationship of glutathione, melanin, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease. Biochem Pharmacol 33:2697-2698
17. Perry TL, Yong VW (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67:269-274
18. Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GP, Jellinger K, Yudim MB (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520
19. Yong VW, Perry TL, Krisman AA (1986) Depletion of glutathione in brainstem of mice by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant treatment. Neurosci Lett 63:56-60
20. Andersen JK, Mo JQ, Hom DG, Lee FY, Harnish P, Hamill RW, McNeill TH (1996) Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J Neurochem 67:2164-2171
21. Masuoka DT, Jonsson G, Finch CE (1979) Aging and unusual catecholamine-containing structures in the mouse brain. Brain Res 169:335-341
22. McNeill TH, Koek LL, Haycock JW (1984) Age-correlated changes in dopaminergic nigrostriatal perikarya of the C57BL/6Nni mouse. Mech Ageing Dev 24:293-307
23. Felten DL, Felten SY, Fuller RW, Romano DT, Smalstig EB, Wong DT, Clemens JA (1992) Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged F344 rats. Neurobiol Aging 13:339-351
24. Pileblad E, Magnusson T (1990) Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexen-1-one. Life Sci 47:2333-2342
25. Paxinos G, Franklin WBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
26. DiChiara G, Morelli M (1993) Dopamine-acetylcholine-glutamate interactions in the striatum: a working hypothesis. Adv Neurol 60:102-106
27. Chéramy A, Desce JM, Godeheu, Glowinski J (1994) Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes. Neurochem Int 25:145-154
28. Morari M, O'Connor WT, Darvelid M, Ungerstedt U, Bianchi C, Fuxe K (1996) Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat. I. Effects of perfusion with tetrodotoxin and low-calcium medium. Neuroscience 72:79-87
29. Janáky R, Varga V, Hermann A, Saransaari P, Oja SS (2000) Mechanisms of L-cysteine neurotoxicity. Neurochem Res 25:1397-1405
30. Cho Y, Bannai S (1990) Uptake of glutamate and cystine in C-6 glioma cells and in cultured astrocytes. J Neurochem 55:2091-2097
31. 2+ in cultured rat forebrain neurons. Neurosci Lett 133:11-14
32. k(A) channels by cysteine oxidation. Nature 352:711-714
33. Maret W (1998) The glutathione redox state and zinc mobilization from metallothionein and other proteins with zinc-sulfur coordination sites. In: Shaw CA (ed) Glutathione in the nervous system. Taylor & Francis, Washington, DC, pp 257-273
34. Hermann A, Varga V, Janáky R, Dohovics R, Saransaari P, Oja SS (2000) Interference of S-nitrosoglutathione with the binding of ligands to ionotropic glutamate receptors in pig cerebral cortical synaptic membranes. Neurochem Res 25:1119-1124
35. Chinta SJ, Andersen JK (2006) Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Rad Biol Med 41:1442-1448
36. Hsu M, Srinivas B, Kumar J, Subramanian R, Andersen J (2005) Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells via an NO-mediated mitochondrial pathway not involving peroxynitrite: implications for Parkinson's disease. J Neurochem 92:1091-1103
37. Li Y-J, Scott WK, Zhang L, Lin P-I, Oliveira SA, Skelly T, Doraiswamy MP, Welsh-Bohmer KA, Martin ER, Haines JL, Pericak-Vance MA, Vance JM (2006) Revealing the role of glutathione S-transferase omega in age-at-onset of Alzheimer and Parkinson diseases. Neurobiol Aging 27:1087-1093
38. Duncan MW, Marini AM, Watters R, Kopin IJ, Markey SP (1992) Zinc, a neurotoxin to cultured neurons, contaminates Cycad flour prepared by traditional Guamanian methods. J Neurosci 12:1523-1537
39. Leviel V, Gobert A, Guibert B (1990) The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39:305-312
40. Krebs MO, Desce JM, Kemel ML, Gauchy C, Godehey G, Chéramy A, Glowinski J (1991) Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56:81-85
41. O'Connor WT, Drew KL, Ungerstedt U (1995) Differential cholinergic regulation of dopamine release in the dorsal and ventral neostriatum of the rat: an in vivo microdialysis study. J Neurosci 15:8353-8361
42. Varga V, Jenei Zs, Janáky R, Saransaari P, Oja SS (1997) Glutathione is an endogenous ligand of rat brain N-methyl-D-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem Res 22:1165-1171
43. Sucher NJ, Lipton SA (1991) Redox modulatory site of the NMDA receptor-channel complex: regulation by oxidized glutathione. J Neurosci Res 30: 582-591
44. Ogita K, Enomoto R, Nakahara F, Ishitsubo N, Yoneda Y (1995) A possible role of glutathione as an endogenous agonist in the N-methyl-D-asparate recognition domain in rat brain. J Neurochem 64:1088-1096
45. Clow DW, Jhamandas K (1989) Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J Pharmacol Exp Ther 248:722-728
46. 3H]dopamine from striatal and cerebral cortical slices from rats with thioacetamide-induced hepatic encephalopathy: different responses to stimulation by potassium ion and agonists of ionotrophic glutamate receptors. Neurochem Res 22:101-106